Brief: Interpace Biosciences Announces Third Quarter 2022 Financial, Business Results
14/11/2022 22:24
Nov 14 (Reuters) - Interpace Biosciences Inc IDXG.PK :
* INTERPACE BIOSCIENCES ANNOUNCES THIRD QUARTER 2022
FINANCIAL AND
BUSINESS RESULTS SALE OF PHARMA SIGNIFICANTLY IMPROVES LIQUIDITY
RESULTING IN REMOVAL OF GOING CONCERN
* INTERPACE BIOSCIENCES INC Q3 REVENUE ROSE 2 PERCENT TO
$8.2
MILLION
Source text for Eikon: ID:nGNX7KWym7
Further company coverage: IDXG.PK
((Reuters.Briefs@thomsonreuters.com;))
Recent news on Interpace Biosciences
See all newsBrief: Interpace Biosciences Announces Reverse Stock Split To Support Proposed Nasdaq Uplisting
Interpace Biosciences Q2 revenue falls despite growth in thyroid business
Brief: Interpace Biosciences Q2 Revenue USD 9.131 Million
Interpace Biosciences Q1 revenue falls
Brief: Interpace Biosciences Q1 Revenue USD 9.032 Million